Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral medicine for treating ischemic encephalopathy and preparation method of oral medicine

A technology for ischemic encephalopathy and drugs, applied in the direction of blood diseases, drug combinations, and pharmaceutical formulas, can solve the problems of unsuitable long-term use, obvious side effects, drug dependence, etc., and achieve the protection of ischemic brain tissue without toxic side effects , the effect of increasing blood supply

Pending Publication Date: 2022-02-18
安康市中医医院
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the disease is mainly treated with western medicine, such as flunarizine hydrochloride, nicergoline, idebenone, Xuesaitong, cinnarizine, etc. After taking it for a long time, patients will develop dependence on the drug, and at the same time, they will develop varying degrees of Drug resistance, obvious side effects, not suitable for long-term use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] An oral medicine for treating ischemic encephalopathy, prepared from the following raw materials in parts by weight:

[0023] 20 parts of Danshen, 20 parts of Tribulus terrestris, 20 parts of Ginkgo biloba, 15 parts of Acanthopanax, 15 parts of Schisandra, 10 parts of Uncaria, 15 parts of Gastrodia elata, 15 parts of Achyranthes bidentata, 10 parts of calamus, 10 parts of Polygonum cuspidatum, 10 parts of leech , 10 parts of mulberry, 10 parts of Angelica dahurica, 10 parts of rhodiola, 10 parts of ginger pinellia, 10 parts of Atractylodes macrocephala, 10 parts of angelica, 10 parts of Radix Ophiopogon japonicus, 10 parts of spider incense, and 5 parts of licorice.

Embodiment 2

[0025] An oral medicine for treating ischemic encephalopathy, prepared from the following raw materials in parts by weight:

[0026] 30 parts of Danshen, 30 parts of Tribulus terrestris, 30 parts of Ginkgo biloba, 20 parts of Acanthopanax, 20 parts of Schisandra, 15 parts of Uncaria, 20 parts of Gastrodia elata, 20 parts of Achyranthes bidentata, 15 parts of calamus, 15 parts of Polygonum cuspidatum, 15 parts of leech , 15 parts of mulberry, 15 parts of Angelica, 15 parts of rhodiola, 15 parts of ginger Pinellia, 15 parts of Atractylodes macrocephala, 15 parts of angelica, 15 parts of Radix Ophiopogon japonicus, 15 parts of spider incense, and 10 parts of licorice.

Embodiment 3

[0028] An oral medicine for treating ischemic encephalopathy, prepared from the following raw materials in parts by weight:

[0029] 25 parts of Danshen, 25 parts of Tribulus terrestris, 25 parts of Ginkgo biloba, 17.5 parts of Acanthopanax, 17.5 parts of Schisandra, 12.5 parts of Uncaria, 17.5 parts of Gastrodia elata, 17.5 parts of Achyranthes bidentata, 12.5 parts of calamus, 12.5 parts of Polygonum cuspidatum, 12.5 parts of leech , 12.5 parts of mulberry, 12.5 parts of Angelica dahurica, 12.5 parts of rhodiola, 12.5 parts of ginger Pinellia, 12.5 parts of Atractylodes macrocephala, 12.5 parts of angelica, 12.5 parts of Ophiopogon japonicus, 12.5 parts of spider incense, 7.5 parts of licorice.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oral medicine for treating ischemic encephalopathy and a preparation method of the oral medicine. The medicine is prepared from the following raw materials in parts by weight: 20-30 parts of salvia miltiorrhiza, 20-30 parts of tribulus terrestris, 20-30 parts of folium ginkgo, 15-20 parts of acanthopanax, 15-20 parts of schisandra chinensis, 10-15 parts of uncaria, 15-20 parts of gastrodia elata, 15-20 parts of achyranthes bidentata, 10-15 parts of acorus calamus, 10-15 parts of polygonum cuspidatum, 10-15 parts of leech, 10-15 parts of mulberry, 10-15 parts of radix angelicae, 10-15 parts of rhodiola rosea, 10-15 parts of ginger processed pinellia, 10-15 parts of bighead atractylodes rhizome, 10-15 parts of angelica sinensis, 10-15 parts of radix ophiopogonis, 10-15 parts of valeriana jatamansi jones and 5-10 parts of radix glycyrrhizae. The traditional Chinese medicine has the effects of promoting blood circulation to remove blood stasis, eliminating thrombus, dredging collaterals, dispelling wind, dredging collaterals, reducing phlegm and inducing resuscitation, and can effectively inhibit thrombus formation and neurological dysfunctions such as cerebral tissue ischemia, hypoxia and necrosis.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine preparations, in particular to an oral medicine for treating ischemic encephalopathy and a preparation method thereof. Background technique [0002] Ischemic encephalopathy refers to various reasons, such as poisoning, cerebral arteriosclerosis, etc., which cause ischemia and hypoxia to cause damage to brain cells. Clinical manifestations include drowsiness, disturbance of consciousness, coma, convulsions, convulsions, unresponsiveness, overexcitement, irritability, involuntary trembling of limbs, increased muscle tension, severe decrease in muscle tension, limb paralysis, and loss of various physiological reflexes. Irregular breathing or apnea, shortness of breath, chest tightness, wheezing, difficulty breathing, etc. Often called a stroke. At present, the disease is mainly treated with western medicine, such as flunarizine hydrochloride, nicergoline, idebenone, Xuesaitong, cinnarizi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8988A61P9/10A61P7/02A61P25/00A61K35/62
CPCA61K36/537A61K36/185A61K36/16A61K36/254A61K36/79A61K36/57A61K36/74A61K36/8988A61K36/21A61K36/888A61K36/704A61K35/62A61K36/605A61K36/232A61K36/41A61K36/8888A61K36/284A61K36/8968A61K36/84A61K36/484A61P9/10A61P7/02A61P25/00A61K2236/333A61K2236/19A61K2300/00
Inventor 张超潘平康陈亮唐勇
Owner 安康市中医医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products